Skip to content
10-Q

Quarterly Report

ASSURED PHARMACY, INC.

0001117768-13-000578

← back to feed
Filed
Nov 14, 2013 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2013 · Nov 7, 2013 6.79M sh
Stockholders Equity Q3 2013 · Sep 30, 2013 −$9.4M
Stockholders Equity Q3 2013 · Dec 31, 2012 −$6.49M
Current Liabilities Q3 2013 · Sep 30, 2013 $10.29M
Current Liabilities Q3 2013 · Dec 31, 2012 $7.57M
Total Liabilities Q3 2013 · Sep 30, 2013 $10.57M
Total Liabilities Q3 2013 · Dec 31, 2012 $8.71M
Current Assets Q3 2013 · Sep 30, 2013 $946.47K
Current Assets Q3 2013 · Dec 31, 2012 $1.26M
Total Assets Q3 2013 · Sep 30, 2013 $1.18M
Total Assets Q3 2013 · Dec 31, 2012 $2.22M
Capex Q3 2013 · Sep 30, 2012 $21.29K
Operating Cash Flow Q3 2013 · Sep 30, 2012 −$409.07K
Cash And Equivalents Q3 2013 · Sep 30, 2012 $6.17K
Cash And Equivalents Q3 2013 · Dec 31, 2011 $23.32K
Sga Expense restated Q3 2013 · Sep 30, 2012 $573.6K
Sga Expense restated Q3 2013 · Sep 30, 2012 $1.77M
Net Income restated Q3 2013 · Sep 30, 2012 −$1.4M
Net Income Q3 2013 · Sep 30, 2012 −$3.52M
Gross Profit restated Q3 2013 · Sep 30, 2012 $392.69K
Gross Profit restated Q3 2013 · Sep 30, 2012 $984.29K
Cost Of Revenue restated Q3 2013 · Sep 30, 2012 $1.1M
Cost Of Revenue restated Q3 2013 · Sep 30, 2012 $3.11M
Revenue restated Q3 2013 · Sep 30, 2012 $1.49M
Revenue restated Q3 2013 · Sep 30, 2012 $4.09M